Contributor Page
Torys LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 416 865 0040
Fax: +1 416 865 7380
79 Wellington St. W.
Box 270, TD South Tower
Toronto
Ontario
M5K 1N2
Canada
By Glen Johnson, Rima Ramchandani
New diversity disclosure requirements will be effective for annual meetings of public CBCA corporations beginning on January 1, 2020.
By Brigitte Goulard, Molly Reynolds, Ronak Shah, Colette Koopman (Summer Student)
Following hearings held earlier this year, the Standing Senate Committee on Banking, Trade and Commerce (the Committee) has tabled its report titled "Open Banking: What it Means for You" (report).
By Eileen McMahon, Teresa Reguly, Yolande Dufresne, Yu Seon Gadsden-Chung
The final regulations on new cannabis products were promulgated in the Canada Gazette, Part II, on June 26 and will come into force on October 17
By Peter Aziz, Brigitte Goulard, John Terry, Gillian Dingle, Nick Kennedy
The naming provisions of the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (PCMLTFA) were amended on June 21 when Bill C-97
By Andrew Bernstein, John Terry, Dennis Mahony, Tyson Dyck, Yael Bienenstock
The Ontario Court of Appeal has confirmed in a 4-1 decision that Parliament has the power to enact a minimum national price on greenhouse gas
By Molly Reynolds, Thomas Yeo, Zhonghui (Sue) Fei
The federal government's plan to revitalize the access to information framework has commenced. The first phase, Bill C-58: An Act to amend the Access to Information Act
By Teresa Reguly, Yolande Dufresne, Yu Seon Gadsden-Chung
In 2018, the Canadian government created the Advisory Council on the Implementation of National Pharmacare (the Council) to advise the government on introducing a national insurance program for prescription drugs, known as...
By Rebecca Wise, Davida Shiff
The Ontario Court of Appeal confirmed in Mikelsteins v. Morrison Hershfield Limited1 that the terms of a shareholders'
By Andrew Shaughnessy, Eileen McMahon, Teresa Reguly
The Federal Court has dismissed an application for judicial review by Alexion Pharmaceuticals Inc. (Alexion) in relation to a decision of the Patented Medicine Prices
By Brigitte Goulard, Myriam Seers
Canadian businesses, organizations and individuals who engage in advertising need to be aware of the recently enacted Elections Modernization Act,
By Gwen Watson, Andrew Wong, Richard Johnson, Judah (Ari) Feder, Joshua Morry
Bill C-82, An Act to implement a multilateral convention to implement tax treaty related measures to prevent base erosion and profit shifting, has received royal assent.
By Michelle Nelles, Michele Clarizio, Brianna Pioli
As the cannabis sector continues to grow, there has been an increase in trademark filings—175% growth from March 2018—with a rise in legal disputes accompanying the trend.
By Craig Maurice, Richard Johnson, Jennifer Lennon
The Government released draft legislative proposals (Proposals) on June 17 to implement the changes to the employee stock option tax regime announced in the 2019 Federal Budget (Budget).
By Rima Ramchandani, David Seville
Canada's securities regulators have published their three-year business plan for 2019–2022. Streamlining regulation without reducing investor protection is identified as a key mandate—consistent
By Eileen McMahon, Teresa Reguly, Michele Clarizio
The Canadian government has published proposed amendments to the Food and Drug Regulations (Regulations) that will improve access to unauthorized human drugs through the Special Access Program (SAP)
Contributor's Topics
More...